Ae Model News Today : Breaking News, Live Updates & Top Stories | Vimarsana

In Novartis Pharms. Corp., Inc. v. Accord Healthcare, the Federal Circuit issued a helpful decision concerning the not-often-discussed written description requirement. The panel specifically addressed whether sufficient written description can exist for claim limitations. ....

United States , Novartis Pharms , Jcorp Inc , Novartis Pharmaceuticals Corporation Inc , District Court , Pharm United States Inc , Accord Healthcare Inc , Inphi Corp , Netlist Inc , Pharm Co Ltd , Federal Circuit , Patent Owners , Pharmaceuticals Corporation , Prophetic Trial , Novartis Pharmaceuticals Corporation , Federal Circuit , Claim Limitations , Ec Pharm Co , Ae Model , Written Disclosure , Patent Infringement Suit ,